Reboxetine use in the treatment of attention-deficit/hyperactivity disorder
- PMID: 17201625
- DOI: 10.1089/cap.2006.16.803
Reboxetine use in the treatment of attention-deficit/hyperactivity disorder
Comment on
-
Reboxetine as an optional treatment for hyperkinetic conduct disorder: a prospective open-label trial.J Child Adolesc Psychopharmacol. 2005 Apr;15(2):259-69. doi: 10.1089/cap.2005.15.259. J Child Adolesc Psychopharmacol. 2005. PMID: 15910210 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
